Julie Clark
Hoofd Techniek/Wetenschap/O&O bij OPTHEA LIMITED
Actieve functies van Julie Clark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OPTHEA LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-02-2024 | - |
Loopbaan van Julie Clark
Eerdere bekende functies van Julie Clark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | - | 22-10-2021 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2011 | 01-10-2012 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Hoofd Techniek/Wetenschap/O&O | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Opleiding van Julie Clark
| Wake Forest School of Medicine | Doctorate Degree |
| Wake Forest University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Australië | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| OPTHEA LIMITED | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Beurs
- Insiders
- Julie Clark
- Ervaring
